Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 465081생성일: 2026년 10월 26일
Triethylamine → 11-(2-(2-((Diethylamino)methyl)-1-piperidinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one
https://huagongshe.com/reaction/465081
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Triethylamine | HCID 8471 | — |
| 반응물 | Ethyl chloroformate | HCID 10928 | — |
| 반응물 | Sodium Hydroxide | HCID 14798 | — |
| 반응물 | 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one | HCID 70169 | — |
| 용매 | Tetrahydrofuran | HCID 8028 | — |
| 생성물 | 11-(2-(2-((Diethylamino)methyl)-1-piperidinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one | HCID 107867 | 29.9% |
반응 단계
Ethyl chlorocarbonate (11.0 g, 0.101 mol) is added dropwise, at 0° C., to a suspension of 2-[(diethylamino)methyl]-1-piperidino acetic acid (22.83 g, 0.1 mol) in dry tetrahydrofuran (200 ml). Then, 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one (21.12 g, 0.1 mol) and triethylamine (20.24 g, 0.2 mol) are added to the resulting suspension which is then stirred for a further hour at 0° C. and then for 4 hours at ambient temperature. The mixture is poured into 2N sodium hydroxide solution (1.6 liters), extracted exhaustively with dichloromethane, the organic phase concentrated to dryness and the residue purified by recrystallization from ethanol and from methanol. Colorless crystals (6.3 g) are obtained, mp. 226°-228° C., which were shown by thin layer chromatography, mixed melting point and IR spectrum to be identical to a sample prepared according to Example 34.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US04550107 |
|---|
| 출처 데이터셋 | uspto-grants-1985_10 |
|---|
| ORD ID | ord-901753c25af7418f9c10fcb008b79f6c |
|---|
| 출처 메모 | uspto-grants-1985_10 |
|---|